Connect with us

Health

Alzheimer’s blood test achieves faster diagnoses, high accuracy at Mayo Clinic

Published

on

Alzheimer’s blood test achieves faster diagnoses, high accuracy at Mayo Clinic

Join Fox News for access to this content

Plus special access to select articles and other premium content with your account – free of charge.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

With nearly seven million Americans currently living with Alzheimer’s disease — and 13 million projected to have the illness by 2050 — early diagnosis and treatment are more urgent than ever.

To help address this, Mayo Clinic has announced a new, non-invasive blood test that detects a protein in the brain that signals Alzheimer’s.

Advertisement

The goal, doctors say, is for this test to offer a convenient, less invasive alternative to traditional diagnostic methods.

‘REVERSING’ ALZHEIMER’S: HERE ARE EXERCISES TO MAKE THE BRAIN MORE RESILIENT

Fox News Digital spoke to Dr. Alicia Algeciras-Schimnich, professor of laboratory medicine and pathology at Mayo Clinic Rochester in Minnesota, about the new test and what it means for Alzheimer’s patients and their families.

“This is the first Alzheimer’s disease blood test offered at Mayo Clinic Laboratories,” said Algeciras-Schimnich, who led the clinical validation study to gauge how well the test performed.

A new, non-invasive blood test detects a protein in the brain that signals Alzheimer’s, Mayo Clinic (not pictured) announced. (iStock)

Advertisement

“While there are other commercial blood tests for Alzheimer’s disease, the uniqueness of our test is its high accuracy rate.”

How does it work?

One of the hallmark features in the brains of patients with Alzheimer’s disease is the formation of plaque containing a protein known as beta amyloid.  

“The pTau217 assay assesses the accumulation of beta amyloid in the brain by measuring the amount of phosphorylated Tau 217 (p-Tau217) in the test sample,” said Algeciras-Schimnich.

EXPERIMENTAL ALZHEIMER’S DRUG GETS FDA ADVISORY PANEL’S THUMBS-UP: ‘PROGRESS IS HAPPENING’

Accumulation of beta amyloid in the brain can also be evaluated by imaging techniques, such as PET scans or cerebrospinal fluid (CSF) biomarkers, the doctor noted — but those methods have some limitations. 

Advertisement

“The PET scan to evaluate beta amyloid is expensive and not a widely available technology,” said Algeciras-Schimnich. 

The Mayo Clinic is a nonprofit medical practice and medical research group based in Rochester, Minnesota. Mayo Clinic has announced a new, non-invasive blood test to help determine if patients have Alzheimer’s. (iStock)

“And the CSF collection requires an invasive technique to remove spinal fluid, so it is also not widely used.”

The Alzheimer’s disease blood biomarkers serve as a non-invasive tool that can improve access for patients who need answers, she said.

How accurate is it?

In patients with symptoms of cognitive decline, the blood test has a sensitivity of 92% and a specificity of 96%. 

Advertisement

“Sensitivity measures the ability of the test to correctly identify patients with the disease, while specificity measures the ability of the test to correctly identify those without the disease,” Algeciras-Schimnich explained.

“A blood-based test not only offers convenience, but could help transform Alzheimer’s disease research.”

Patients who take the test are classified as positive or negative for the presence of the accumulation of beta amyloid. 

“In a small number of patients, the test will not be able to differentiate between the presence or absence of beta amyloid,” said Algeciras-Schimnich.  

Patients who take the test are classified as positive or negative for the presence of the accumulation of beta amyloid.  (iStock)

Advertisement

“These patients will need additional tests to determine if they are positive or negative for the accumulation of beta amyloid.”

The test is purposely designed to minimize the number of false positive results as compared to other tests, the doctor said.

                                                         

“The test has been validated at Mayo Clinic through a rigorous quality process backed by scientific experts and clinicians,” Algeciras-Schimnich said.

The test is currently available for clinicians to order through Mayo Clinic Laboratories. 

Advertisement

Evidence of Alzheimer’s disease is seen on PET scans at the Center for Alzheimer Research and Treatment (CART) at Brigham and Women’s Hospital in Boston, Massachusetts, March 2023. (REUTERS/Brian Snyder/File Photo)

“Since it is a blood test, it requires a blood draw by a phlebotomist, so anyone who is averse to blood should be aware,” said Algeciras-Schimnich.

At this point, the test is only recommended for individuals 50 years of age and older who have symptoms of mild cognitive impairment or mild dementia.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“We don’t yet have enough data to support how the test performs in younger individuals,” Algeciras-Schimnich said.

Advertisement

Michelle Rankine, PhD, a certified dementia practitioner in Texas, is not associated with Mayo Clinic but shared her comments on the test’s potential.

Accumulation of beta amyloid in the brain can also be evaluated by imaging techniques, such as PET scans or cerebrospinal fluid (CSF) biomarkers, the doctor noted — but those methods have some limitations.  (Michael Robinson Chávez/The Washington Post)

“As the global burden of Alzheimer’s continues to rise, a blood-based test not only offers convenience, but could help transform Alzheimer’s disease research,” Rankine told Fox News Digital. 

“This could make screening more efficient in averting the clinical onset of Alzheimer’s disease.”

For more Health articles, visit www.foxnews/health 

Advertisement

“This innovation addresses a growing need and could accelerate development of new treatments, improve patient evaluation and care, and potentially even allow for early intervention before symptoms become worse,” Rankine added.

Health

Ancient plague mystery cracked after DNA found in 4,000-year-old animal remains

Published

on

Ancient plague mystery cracked after DNA found in 4,000-year-old animal remains

NEWYou can now listen to Fox News articles!

Long before the Black Death killed millions across Europe in the Middle Ages, an earlier, more elusive version of the plague spread across much of Eurasia.

For years, scientists were unsure how the ancient disease managed to spread so widely during the Bronze Age, which lasted from roughly 3300 to 1200 B.C., and stick around for nearly 2,000 years, especially since it wasn’t spread by fleas like later plagues. Now, researchers say a surprising clue may help explain it, a domesticated sheep that lived more than 4,000 years ago.

Researchers found DNA from the plague bacterium Yersinia pestis in the tooth of a Bronze Age sheep discovered in what is now southern Russia, according to a study recently published in the journal Cell. It is the first known evidence that the ancient plague infected animals, not just people, and offers a missing clue about how the disease spread.

SCIENTISTS CRACK THE CODE ON NEW VACCINE FOR DEADLY PLAGUE BACTERIA

Advertisement

“It was alarm bells for my team,” study co-author Taylor Hermes, a University of Arkansas archaeologist who studies ancient livestock and disease spread, said in a statement. “This was the first time we had recovered the genome from Yersinia pestis in a non-human sample.”

A domesticated sheep, likely similar to this one, lived alongside humans during the Bronze Age. (iStock)

And it was a lucky discovery, according to the researchers.

“When we test livestock DNA in ancient samples, we get a complex genetic soup of contamination,” Hermes said. “This is a large barrier … but it also gives us an opportunity to look for pathogens that infected herds and their handlers.”

DEADLY BACTERIA THAT DOOMED NAPOLEON’S ARMY DISCOVERED 213 YEARS AFTER RUSSIAN RETREAT

Advertisement

The highly technical and time-consuming work requires researchers to separate tiny, damaged fragments of ancient DNA from contamination left by soil, microbes and even modern humans. The DNA they recover from ancient animals is often broken into tiny pieces sometimes just 50 “letters” long, compared to a full human DNA strand, which contains more than 3 billion of those letters.

Animal remains are especially tough to study because they are often poorly preserved compared to human remains that were carefully buried, the researchers noted.

The finding sheds light on how the plague likely spread through close contact between people, livestock and wild animals as Bronze Age societies began keeping larger herds and traveling farther with horses. The Bronze Age saw more widespread use of bronze tools, large-scale animal herding and increased travel, conditions that may have made it easier for diseases to move between animals and humans.

When the plague returned in the Middle Ages during the 1300s, known as the Black Death, it killed an estimated one-third of Europe’s population.

Advertisement

The discovery was made at Arkaim, a fortified Bronze Age settlement in the Southern Ural Mountains of present-day Russia near the Kazakhstan border. (iStock)

“It had to be more than people moving,” Hermes said. “Our plague sheep gave us a breakthrough. We now see it as a dynamic between people, livestock and some still unidentified ‘natural reservoir’ for it.”

CLICK HERE FOR MORE LIFESTYLE STORIES

Researchers believe sheep likely picked up the bacteria from another animal, like rodents or migratory birds, that carried it without getting sick and then passed it to humans. They say the findings highlight how many deadly diseases begin in animals and jump to humans, a risk that continues today as people move into new environments and interact more closely with wildlife and livestock.

“It’s important to have a greater respect for the forces of nature,” Hermes said.

Advertisement

The study is based on a single ancient sheep genome, which limits how much scientists can conclude, they noted, and more samples are needed to fully understand the spread.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The researchers plan to study more ancient human and animal remains from the region to determine how widespread the plague was and which species may have played a role in spreading it. 

Researchers (not pictured) found plague-causing Yersinia pestis DNA in the remains of a Bronze Age sheep. (iStock)

They also hope to identify the wild animal that originally carried the bacteria and better understand how human movement and livestock herding helped the disease travel across vast distances, insights that could help them better anticipate how animal-borne diseases continue to emerge.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The research was led by scientists at the Max Planck Institute for Infection Biology, with senior authors Felix M. Key of the Max Planck Institute for Infection Biology and Christina Warinner of Harvard University and the Max Planck Institute for Geoanthropology.

The research was supported by the Max Planck Society, which has also funded follow-up work in the region.

Continue Reading

Health

Scientists pinpoint why COVID vaccine may trigger heart inflammation in certain people

Published

on

Scientists pinpoint why COVID vaccine may trigger heart inflammation in certain people

NEWYou can now listen to Fox News articles!

POST-DOSE PATTERN — New research reveals why the COVID vaccine can trigger heart issues, especially in one group

PREVENTION PAYOFF — Simple lifestyle changes could slash heart attack risk for millions

A new study has identified why mRNA COVID-19 vaccines could trigger heart issues, especially in one demographic. (iStock)

SMOKE SCREEN — A major cannabis study finds little proof for popular medical claims and flags big dangers

Advertisement

HIDDEN LINK — A common dental health issue may hint at a dangerous cardiovascular condition

SIGN UP FOR OUR HEALTH NEWSLETTER

SCREENING DEBATE A new study questions whether annual mammograms are necessary for most women

SUPER SPREAD — An “aggressive” new flu variant sweeps the globe as doctors warn of severe symptoms

The flu season has intensified as the new H3N2 variant causes severe illness worldwide. (iStock)

Advertisement

DANGEROUS DEFICIT — A nutrient deficiency has been linked to heart disease risk for millions

LIKE WHAT YOU’RE READING? CLICK HERE FOR MORE HEALTH NEWS

CORONARY CHRISTMAS — Holiday heart attacks spike as doctors share hidden triggers and prevention tips

Continue Reading

Health

Aging-related joint disorder increasingly affects people under 40, study finds

Published

on

Aging-related joint disorder increasingly affects people under 40, study finds

NEWYou can now listen to Fox News articles!

Cases of gout are rising in younger individuals, according to a global study.

The condition, which is a type of inflammatory arthritis, steadily increased in people aged 15 to 39 between 1990 and 2021, researchers in China announced.

Although rates vary widely between countries, the total number of young people with the condition is expected to continue rising through 2035.

WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT

Advertisement

The study, published in the journal Joint Bone Spine, investigated 2021 data from the Global Burden of Disease (GBD), spanning 204 countries within the 30-year timeframe.

The data measured gout prevalence, incidence and years lived with disability, tracking global trends over time. The results showed a global increase across all three outcomes.

Gout is expected to continue rising in young people through 2035. (iStock)

Prevalence and disability years increased by 66%, and incidence rose by 62%. In 2021, 15- to 39-year-olds accounted for nearly 14% of new gout cases globally, the study found.

Men from 35 to 39 years old and people in high-income regions had the highest burden, but high-income North America topped the list for highest rates.

Advertisement

‘SKINNY FAT’ WARNING ISSUED AS STUDY FINDS HIDDEN OBESITY BEHIND NORMAL BMI

Men were also found to have lived more years with gout due to high BMI, while women tended to have the condition as a link to kidney dysfunction, the study noted.

The total number of cases is expected to increase globally due to population growth, but the study projected that rates per population would decrease.

The researchers noted that data quality, especially in low-income settings, could have posed a limitation to the broad GBD data.

What is gout?

Gout is a common form of arthritis involving sudden and severe attacks of pain, swelling, redness and tenderness in the joints, according to Mayo Clinic. It most often occurs in the big toe.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The condition occurs when urate crystals accumulate in the joint. These form when there are high levels of uric acid in the blood, which the body produces when it breaks down a natural substance called purines.

A gout flare-up can happen at any time, often at night, causing the affected joint to feel hot, swollen, tender and sensitive to the touch.

Urate crystals, described as sharp and needle-like, build up in the joint, causing intense pain and swelling. (iStock)

Purines can also be found in certain foods, like red meat or organ meats like liver and some seafood, including anchovies, sardines, mussels, scallops, trout and tuna, according to the Mayo Clinic. Alcoholic drinks, especially beer, and drinks sweetened with fruit sugar can also lead to higher uric acid levels.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Uric acid will typically dissolve in the blood and pass through the kidneys into urine, but when the body produces too much or too little uric acid, it can cause a build-up of urate crystals. These are described by the Mayo Clinic as sharp and needle-like, causing pain, inflammation and swelling in the joint or surrounding tissue.

Risk factors for gout include a diet rich in high-purine foods and being overweight, which causes the body to produce more uric acid and the kidneys to have trouble eliminating it.

Experts urge patients to seek medical attention for gout flare-ups. (iStock)

Certain conditions like untreated high blood pressure, diabetes, obesity, metabolic syndrome and heart and kidney diseases can increase the risk of gout, as well as certain medications.

Advertisement

A family history of gout can also increase risk. Men are more likely to develop the condition, as women tend to have lower uric acid levels, although symptoms generally develop after menopause.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Untreated gout can cause worsening pain and joint damage, experts caution. It may also lead to more severe conditions, such as recurrent gout, advanced gout and kidney stones.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The Mayo Clinic advises patients to seek immediate medical care if a fever occurs or if a joint becomes hot and inflamed, which is a sign of infection. Certain anti-inflammatory medications can help treat gout flares and complications.

Advertisement

Fox News Digital reached out to the researchers for comment.

Continue Reading

Trending